Literature DB >> 30193318

Caspase-2 Mediates Site-Specific Retinal Ganglion Cell Death After Blunt Ocular Injury.

Chloe N Thomas1, Adam M Thompson1, Eleanor McCance1, Martin Berry1, Ann Logan1, Richard J Blanch1,2, Zubair Ahmed1.   

Abstract

Purpose: Ocular trauma is common in civilian and military populations. Among other injuries, closed globe blunt ocular trauma causes acute disruption of photoreceptor outer segments (commotio retinae) and retinal ganglion cell (RGC) death (traumatic optic neuropathy [TON]), both of which permanently impair vision. Caspase-2-dependent cell death is important and evidenced in models of RGC degeneration. We assessed the role of caspase-2 as a mediator of RGC and photoreceptor death in a rat blunt ocular trauma model.
Methods: Bilateral ballistic closed globe blunt ocular trauma was induced in female Lister-hooded rats and caspase-2 cleavage and localization assessed by Western blotting and immunohistochemistry. Retinal caspase-2 was knocked down by intravitreal injection of caspase-2 small interfering RNA (siCASP2). In retinal sections, RGC survival was assessed by BRN3A-positive cell counts and photoreceptor survival by outer nuclear layer (ONL) thickness, respectively. Retinal function was assessed by electroretinography (ERG).
Results: Raised levels of cleaved caspase-2 were detected in the retina at 5, 24, and 48 hours after injury and localized to RGC but not photoreceptors. Small interfering RNA-mediated caspase-2 knockdown neuroprotected RGC around but not in the center of the injury site. In addition, caspase-2 knockdown increased the amplitude of the ERG photopic negative response (PhNR) at 2 weeks after injury. However, siCASP2 was not protective for photoreceptors, suggesting that photoreceptor degeneration in this model is not mediated by caspase-2. Conclusions: Caspase-2 mediates death in a proportion of RGC but not photoreceptors at the site of blunt ocular trauma. Thus, intravitreally delivered siCASP2 is a possible therapeutic for the effective treatment of RGC death to prevent TON.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30193318     DOI: 10.1167/iovs.18-24045

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Isolated-check visual evoked potential: a more sensitive tool to detect traumatic optic neuropathy after orbital fracture.

Authors:  Yanjie Tian; Yinhao Wang; Ziyuan Liu; Xuemin Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-09-09       Impact factor: 3.117

Review 2.  Differential susceptibility of retinal ganglion cell subtypes against neurodegenerative diseases.

Authors:  Ningzhi Zhang; Xuejun He; Yiqiao Xing; Ning Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-17       Impact factor: 3.117

3.  Quantification of Immunostained Caspase-9 in Retinal Tissue.

Authors:  Maria I Avrutsky; Carol M Troy; Crystal K Colón Ortiz; Anna M Potenski; Kendra V Johnson; Claire W Chen; Scott J Snipas; Ying Y Jean
Journal:  J Vis Exp       Date:  2022-07-25       Impact factor: 1.424

4.  High-Mobility Group Box 1 Inhibitor BoxA Alleviates Neuroinflammation-Induced Retinal Ganglion Cell Damage in Traumatic Optic Neuropathy.

Authors:  Jingyi Peng; Jiayi Jin; Wenru Su; Wanwen Shao; Weihua Li; Zhiquan Li; Huan Yu; Yongxin Zheng; Liuxueying Zhong
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

Review 5.  Prospective Application of Activity-Based Proteomic Profiling in Vision Research-Potential Unique Insights into Ocular Protease Biology and Pathology.

Authors:  Hui Peng; John D Hulleman
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

6.  Retinal Ganglion Cells Die by Necroptotic Mechanisms in a Site-Specific Manner in a Rat Blunt Ocular Injury Model.

Authors:  Chloe N Thomas; Adam M Thompson; Zubair Ahmed; Richard J Blanch
Journal:  Cells       Date:  2019-11-26       Impact factor: 6.600

7.  miR-181d-5p Protects against Retinal Ganglion Cell Death after Blunt Ocular Injury by Regulating NFIA-Medicated Astrocyte Development.

Authors:  Jinghua Li; Junyi Liu; Yuanping Zhang; Xu Zha; Hong Zhang; Yongying Tang; Xueying Zhao
Journal:  Mediators Inflamm       Date:  2022-10-08       Impact factor: 4.529

8.  Rapid assessment of ocular drug delivery in a novel ex vivo corneal model.

Authors:  Ghazala Begum; Thomas Leigh; Ella Courtie; Richard Moakes; Gibran Butt; Zubair Ahmed; Saaeha Rauz; Ann Logan; Richard J Blanch
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

9.  Mutant three-repeat tau expression initiates retinal ganglion cell death through Caspase-2.

Authors:  Jennifer Ngolab; Saranya Canchi; Suhail Rasool; Abderrahman Elmaarouf; Kimberly Thomas; Floyd Sarsoza; Jennifer Grundman; Michael Mante; Jazmin Florio; Nimisha Nandankar; Shaina Korouri; Wagner Zago; Eliezer Masliah; Robert A Rissman
Journal:  Neurobiol Dis       Date:  2021-01-29       Impact factor: 5.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.